TRUP vs. ALHC, CLOV, NEUE, BHG, UNH, ELV, CI, HUM, CNC, and MOH
Should you be buying Trupanion stock or one of its competitors? The main competitors of Trupanion include Alignment Healthcare (ALHC), Clover Health Investments (CLOV), NeueHealth (NEUE), Bright Health Group (BHG), UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Centene (CNC), and Molina Healthcare (MOH). These companies are all part of the "hospital & medical service plans" industry.
Trupanion (NASDAQ:TRUP) and Alignment Healthcare (NASDAQ:ALHC) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership and valuation.
Trupanion received 479 more outperform votes than Alignment Healthcare when rated by MarketBeat users. Likewise, 66.41% of users gave Trupanion an outperform vote while only 60.81% of users gave Alignment Healthcare an outperform vote.
Trupanion has a net margin of -2.31% compared to Alignment Healthcare's net margin of -7.81%. Trupanion's return on equity of -9.03% beat Alignment Healthcare's return on equity.
Trupanion has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
Trupanion has higher earnings, but lower revenue than Alignment Healthcare. Trupanion is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
86.2% of Alignment Healthcare shares are owned by institutional investors. 5.5% of Trupanion shares are owned by company insiders. Comparatively, 6.6% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Trupanion currently has a consensus price target of $32.80, suggesting a potential upside of 14.85%. Alignment Healthcare has a consensus price target of $8.69, suggesting a potential upside of 19.59%. Given Alignment Healthcare's higher probable upside, analysts clearly believe Alignment Healthcare is more favorable than Trupanion.
In the previous week, Trupanion had 3 more articles in the media than Alignment Healthcare. MarketBeat recorded 7 mentions for Trupanion and 4 mentions for Alignment Healthcare. Alignment Healthcare's average media sentiment score of 1.09 beat Trupanion's score of 0.80 indicating that Alignment Healthcare is being referred to more favorably in the news media.
Summary
Trupanion beats Alignment Healthcare on 11 of the 19 factors compared between the two stocks.
Get Trupanion News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trupanion Competitors List
Related Companies and Tools
